Bachem stock heads into the open after a 1.7 percent gain

At the close on September 17, 2026, Bachem stock finished at 77.95 CHF on the SIX Swiss Exchange, up 1.3 percent, after trading between 74.05 CHF and 78.75 CHF while the SMI also advanced. Today, investors watch corporate and sector signals into the pre-market.

Bachem stock closed at 77.95 CHF on the SIX Swiss Exchange on September 17, 2026, gaining 1.3 percent from the prior close in a firm session for Swiss equities. The move left the shares 1.7 percent higher at one point intraday and broadly in line with the advance of the Swiss Market Index on the same date.

September 17, 2026 in numbers

Bachem AG (ISIN CH0012530207) ended the September 17, 2026 session on the Swiss Exchange at 77.95 CHF, compared with a previous close of 76.95 CHF, corresponding to a 1.3 percent daily increase. According to quote data for the Swiss Exchange segment, the share traded in a wide intraday range between a low of 74.05 CHF and a high of 78.75 CHF on September 17, 2026, with reported turnover of 112,143 shares in regular trading. Per the same overview, the Swiss Market Index closed at 13,947.31 points on September 17, 2026, so Bachem outperformed the broader Swiss blue-chip benchmark in that session.

A market wrap from Ad-hoc-news noted that Bachem shares rose by around 1.7 percent intraday on September 17, 2026, with the price confirming levels above the 78 CHF mark at the peak of the session. The same report highlighted that the stock had pulled back to a low of 74.05 CHF earlier in the day before recovering into the close, reflecting a notably volatile trading pattern for the session.

Today’s focus for Bachem

Into today’s session on September 18, 2026, Bachem enters the pre-market phase without a newly published company earnings release or dated corporate announcement in the morning feeds, so the previous day’s price action and positioning versus the Swiss Market Index form the immediate backdrop. In the absence of a scheduled Bachem-specific event in the next few days in the available calendars, broader developments in Swiss equities and global risk sentiment are likely to shape trading interest, with investors monitoring sector news and macro indicators that could influence demand for healthcare and life-sciences names such as Bachem.